Journal of Pharmacokinetics and Pharmacodynamics

Papers
(The H4-Index of Journal of Pharmacokinetics and Pharmacodynamics is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Population pharmacokinetic and pharmacodynamic model of propofol externally validated in Korean elderly subjects52
Translational physiologically-based pharmacokinetic model for ocular disposition of monoclonal antibodies50
Development of PBPK model for intra-articular injection in human: methotrexate solution and rheumatoid arthritis case study34
Learning pharmacometric covariate model structures with symbolic regression networks22
Advancing inclusive healthcare through PBPK modelling: predicting the impact of CYP genotypes and enzyme ontogenies on infant exposures of venlafaxine and its active metabolite O-desmethylvenlafaxine 22
Application of different approaches to generate virtual patient populations for the quantitative systems pharmacology model of erythropoiesis17
Achieving big with small: quantitative clinical pharmacology tools for drug development in pediatric rare diseases17
Convolution-based approach for modeling the paliperidone extended release and Long-Acting Injectable (LAI) PK of once-, and three-monthly products administration and for optimizing the development of 16
Current practices for QSP model assessment: an IQ consortium survey14
Characterization of exposure–Clinical Dementia Rating–Sum of Boxes relationship in subjects with early Alzheimer’s disease from the aducanumab Phase 3 trials14
Semi-mechanistic modeling of resistance development to β-lactam and β-lactamase-inhibitor combinations14
Model-informed approach to estimate treatment effect in placebo-controlled clinical trials using an artificial intelligence-based propensity weighting methodology to account for non-specific responses14
Correction: Model-based comparison of subcutaneous versus sublingual apomorphine administration in the treatment of motor fluctuations in Parkinson’s disease13
0.079217910766602